You are requesting information on: Exacis Biotherapeutics Announces Strategic Partnership With CCRM For Specialty Manufacturing Of Services And Investment For Development Of iPSC-Derived mRNA-Engineered NK Cells OmniaBio
Already a member of Cell & Gene or VertMarkets? Sign in now.
In order for our suppliers to better serve your request, please enter specific requirements or questions below: